| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 3 | $6,635.17 | 972 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 3 | $6,635.17 | 972 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 3 | $6,635.17 | 972 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 3 | $6,635.17 | 972 | ||
See activity going back 12 months โ create a free account | ||||||
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Flomenberg Neal Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026. | Sale | 19 | $7.75 | $147.25 | View Details |
| Mar 11, 2026 | Flomenberg Neal Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026. | Sale | 452 | $7.26 | $3,281.52 | View Details |
| Mar 13, 2026 | Flomenberg Neal Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026. | Sale | 501 | $6.40 | $3,206.40 | View Details |
1 more transactions available โ create a free account to see 12 months of history | ||||||